What is the suggested workup for a 35-year-old male with schizophrenia, managed with clozapine (Clozaril), buspirone (Buspar), lorazepam (Ativan), loxapine (Loxitane), quetiapine (Seroquel), and venlafaxine (Effexor), presenting with recurrent falls and dizziness upon standing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Recurrent Falls in a 35-Year-Old Male with Schizophrenia and Orthostatic Dizziness

The primary cause of this patient's recurrent falls is likely medication-induced orthostatic hypotension, requiring medication adjustment and comprehensive vestibular/cardiovascular assessment.

Initial Assessment

Medication Review (Highest Priority)

  • The patient is on multiple medications known to cause orthostatic hypotension:
    • Clozapine: High risk for orthostatic hypotension, especially during initial titration 1
    • Quetiapine: More sedating with risk of transient orthostasis 2
    • Loxapine: Associated with orthostatic effects
    • Lorazepam: Can worsen dizziness and increase fall risk
    • Venlafaxine: May contribute to orthostatic hypotension

Orthostatic Vital Signs

  • Measure blood pressure and heart rate in:
    • Supine position (after 5 minutes of rest)
    • Immediately upon standing
    • After 1-3 minutes of standing
  • Diagnostic criteria for orthostatic hypotension: drop of ≥20 mmHg systolic or ≥10 mmHg diastolic within 3 minutes of standing

Vestibular Assessment

  • Perform Dix-Hallpike maneuver to assess for BPPV
  • Assess for nystagmus
  • Evaluate gait and balance with Romberg test and tandem gait
  • Consider formal vestibular function testing if initial assessment suggests vestibular disorder 3

Laboratory Workup

  • Complete blood count (CBC) with differential (monitor for clozapine-induced neutropenia)
  • Comprehensive metabolic panel (assess electrolytes, renal function)
  • Serum drug levels for clozapine (therapeutic monitoring)
  • Fasting blood glucose and HbA1c (metabolic effects of antipsychotics)
  • Electrocardiogram (ECG) to assess for cardiac conduction abnormalities

Medication Adjustments

Short-term Interventions

  1. Evaluate antipsychotic polypharmacy: The patient is on three antipsychotics (clozapine, quetiapine, and loxapine), which significantly increases fall risk 2
  2. Consider dose reduction of clozapine and/or quetiapine, as these have the strongest orthostatic effects
  3. Adjust timing of medication administration to minimize peak orthostatic effects
  4. Temporarily reduce or discontinue lorazepam, which can worsen dizziness and falls

Long-term Strategy

  1. Simplify antipsychotic regimen: Work toward antipsychotic monotherapy when possible 2
  2. If clozapine is essential: Consider combining with a partial D2 agonist (like aripiprazole) which may allow for clozapine dose reduction while maintaining efficacy 2
  3. Consider pharmacogenetic testing: To optimize dosing based on metabolizer status, especially for clozapine 2

Non-pharmacological Interventions

Fall Prevention Strategies

  • Environmental modifications in hospital room:
    • Remove obstacles and clutter
    • Install grab bars in bathroom
    • Ensure adequate lighting, especially at night
    • Non-slip footwear
  • Supervised ambulation, especially after medication administration
  • Physical therapy consultation for gait training and balance exercises

Patient Education

  • Instruct patient to change positions slowly (supine to sitting, sitting to standing)
  • Encourage adequate hydration (unless contraindicated)
  • Teach physical counterpressure maneuvers to reduce orthostatic symptoms 3

Monitoring Plan

  • Daily orthostatic vital signs
  • Fall risk assessment using standardized tools
  • Regular medication review with focus on minimizing polypharmacy
  • Monitor for improvement in orthostatic symptoms after medication adjustments

Special Considerations

  • Patients with schizophrenia on multiple antipsychotics have significantly higher fall risk than the general population
  • Central nervous system disorders can mimic vestibular disorders and should be considered in the differential diagnosis 3
  • Clozapine's FDA label specifically warns about falls: "Clozapine may cause somnolence, postural hypotension, motor and sensory instability, which may lead to falls and, consequently, fractures or other injuries" 1

By addressing medication-induced orthostatic hypotension as the likely primary cause while conducting a thorough vestibular and cardiovascular assessment, this approach prioritizes both immediate safety and long-term management of this patient's recurrent falls.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vestibular Disorders in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.